This breakthrough enables Linea AI to intelligently analyze and contextualize all forms of content, including complex visual ...

specialty pharmaceutical company focused on rare and orphan diseases, today announces highly positive clinical data from its ongoing Investigator Pediatric Netherton Syndrome (NS) study.

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company ... data from its ongoing Investigator Pediatric Netherton Syndrome (NS) study. Dramatic improvement was ...

Vetter’s Center for Visual Inspection and Logistics will double its cool storage volume by 2028. Vetter, a globally operating CDMO, announced it will be expanding its pharmaceutical materials ...

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ...

But if we can’t ban pharmaceutical ads, we can at least rein them in. Policymakers can play an integral role in addressing the manipulative advertising practices rampant in the industry, while still ...

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced recent corporate ...

The Eylea franchise was in need of a win after an appellate court last week denied the pharma’s bid to block Amgen’s ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

In the complex pharmaceutical market, achieving high levels of brand memorability directly influences patient choices and adherence, making it a critical focus for marketing strategies.

The Phase 2b ASPIRE clinical trial of intravitreal UBX1325 involed patients with diabetic macular edema (DME) who had poor ...

Third expansion stage of Vetter's Center for Visual Inspection and Logistics ... a significant expansion of its pharmaceutical materials warehouse in Ravensburg to meet increasing market demand and ...